Alembic Pharmaceuticals Ltd Share Price Today, Live NSE/BSE Updates

NSEBSE

There is a 15-minute delay in the prices. To check out the live prices, log in to your Ventura account or open one today.

Max

Open883.5

High894.5

Low880.25

Prev. Close885.1

Avg. Traded Price886.89

Volume44,739

MARKET DEPTH

Total bid3.00

Total ask0.00

Orders	Qty	Bid
1	3	885.1
0	0	0
0	0	0
0	0	0
0	0	0

Ask	Qty	Orders
0	0	0
0	0	0
0	0	0
0	0	0
0	0	0

HIGH/LOW

52w

LOW/HIGH

₹880.258 hours ago

₹894.505 hours ago

LOWER/UPPER CIRCUITS

₹706.70

₹1,060.00

Alembic Pharmaceuticals Ltd Stock performance

KEY OBSERVATIONS

positive

negative

neutral

Annual Revenue,rose 7.32%, in the last year to ₹6,714.63 Cr. Its sector's average revenue growth for the last fiscal year was 10.73%.

Price to Earning Ratio,is 27.37, lower than its sector PE ratio of 41.18.

Quarterly Revenue,rose 15.91% YoY to ₹1,917.06 Cr. Its sector's average revenue growth YoY for the quarter was 13.04%.

LONG-TERM PRICE ANALYSIS

Stock return5Y CAGR : 12.86%

Net profit growth 5Y CAGR : 0.8%

Similar stocks

SUNPHARMA₹1,807.20+21.70 (1.22%)

DIVISLAB₹6,430.00+135.50 (2.15%)

TORNTPHARM₹3,799.00+4.60 (0.12%)

CIPLA₹1,512.30+21.40 (1.44%)

DRREDDY₹1,273.50+22.70 (1.81%)

Alembic Pharmaceuticals Limited is involved in manufacturing and marketing of India Formulations, International Generics, and Active Pharmaceutical Ingredients with vertical integration capabilities. Headquartered in Vadodara, Gujarat. It is the flagship company of the pioneering Alembic Group. Close to 40% of its revenues are generated from the US generics business, while 18% of its business comes from third-party API sales. The company’s capabilities also extend to making oral solid injectables in Oncology, general complex injectables and ophthalmology. The company’s manufacturing facility in Sikkim is dedicated for manufacturing its India Formulations.

Grow your wealth with more research recommendations

+91